Pharmacological Treatments against COVID-19 in Pregnant Women
The recent respiratory virus known as SARS-CoV-2 has caused millions of deaths worldwide, causing great uncertainty due to the lack of a specific treatment, which has been mitigated by the use of various drugs traditionally used against other types of pathologies. Pregnancy presents special physiolo...
Enregistré dans:
Auteurs principaux: | Ana Arco-Torres, Jonathan Cortés-Martín, María Isabel Tovar-Gálvez, María Montiel-Troya, Blanca Riquelme-Gallego, Raquel Rodríguez-Blanque |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/27e679a1e9484b3f84a849e6ec623d02 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
COVID-19 Delta Variant-of-Concern: A Real Concern for Pregnant Women With Gestational Diabetes Mellitus
par: Md Mahfuz Al Mamun, et autres
Publié: (2021) -
Differences in pregnancy and perinatal outcomes among symptomatic versus asymptomatic COVID-19-infected pregnant women: a systematic review and meta-analysis
par: Durray Shahwar A. Khan, et autres
Publié: (2021) -
Impact of the SARS-CoV-2 pandemic and first lockdown on pregnancy monitoring in France: the COVIMATER cross-sectional study
par: Alexandra Doncarli, et autres
Publié: (2021) -
Prevalence and Risk Factors of SARS-CoV-2 Infection among Parturients and Newborns from Luanda, Angola
par: Cruz S. Sebastião, et autres
Publié: (2021) -
Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis
par: Vineet D. Menachery, et autres
Publié: (2017)